Market expectations are for Uniform ROA expansion, but management is concerned about debt maturities, resident retention, and prelease rates...
Read MoreThe Latest from
-
September 21, 2018
This week the Valens Research team highlights our most interesting equity insight from across our tools and our analysis. The market is worried about the legacy business, and is not capturing the strong momentum in their execution into a stickier higher value add business...
Read More -
September 20, 2018
Highlighted Top Ideas CVI – CVR Energy, Inc. RIG – Transocean Ltd. X – United States Steel Corporation Other Recent Analyses R – Ryder System, Inc. FCX – Freeport-McMoRan Inc....
Read More -
September 20, 2018
Higher highs and higher lows, fundamentally and technically
Market technicians have many metrics they look at when observing the charts. One trusty tool that many come back to is looking for charts with consistent higher highs and higher lows in stock price. This indicates positive momentum and is a favorable set-up....
Read More -
September 19, 2018
Each week the Valens Securities team highlights our most interesting insights from across our tools and our analysis, including individual company industry and macro insights Top Highlight: Sanofi Other Highlights: AGN, EXPE, NVDA Other Recent Analyses: ABT, AMGN, BSX, CVI, FCX, FOXA, GM, MEG:CAN, MRK, NESN:CHE, PYPL, R, RIG, TMUS, UNP...
Read More -
September 19, 2018
Broadcom Inc. (AVGO:USA) currently trades below corporate averages relative to UAFRS-based (Uniform) Earnings, with a 10.2x Uniform P/E, implying bearish expectations for the firm. Moreover, they may be concerned about their current business model, wireless products segment, and volatility in broadband products...
Read More -
September 18, 2018
Royal Caribbean Cruises Ltd (RCL:USA) currently trades below historical averages relative to UAFRS-based (Uniform) Earnings, with a 17.9x Uniform P/E. At these levels, markets are pricing in bearish expectations for the firm, but management is confident in tailwinds across the industry and overall performance...
Read More -
September 17, 2018
Each week, Valens focuses on several companies that were analyzed in the prior week, where material distortions caused by as-reported GAAP accounting need to be corrected to understand a company’s economic fundamentals. This week, we focus on Lam Research Corporation (LRCX), AMAG Pharmaceuticals, Inc. (AMAG), SBA Communications Corporation (SBAC)...
Read More -
September 17, 2018
Sanofi (SAN:FRA) currently trades near recent averages relative to UAFRS-based (Uniform) Earnings, with a 16.2x Uniform P/E. At these levels, the market has bearish expectations for the firm, however, management is confident in their price limiting strategy and growth in emerging markets...
Read More -
September 14, 2018
Allergan plc (AGN:USA) currently trades well below corporate averages relative to UAFRS-based (Uniform) Earnings, with an 8.3x Uniform P/E, implying bearish expectations for the firm. However, management is confident in their R&D productivity and market positioning...
Read More -
September 14, 2018
This week the Valens Research team highlights our most interesting equity insight from across our tools and our analysis. Management’s success in operating their core business, intelligent acquisitions to drive growth, low market expectations and growing management confidence in their outlook are a diagnosis for equity upside...
Read More -
September 13, 2018
NVIDIA Corporation (NVDA:USA) currently trades above recent averages relative to UAFRS-based (Uniform) Earnings, with a 29.1x Uniform P/E. At these levels, the market is pricing in bullish expectations for the firm, however management has concerns about demand and performance sustainability...
Read More